Observe Medical ASA (OSL:OBSRV)
Norway · Delayed Price · Currency is NOK | Market Cap | 107.56M +23.4% |
| Revenue (ttm) | 21.91M +32.2% |
| Net Income | -24.03M |
| EPS | -0.19 |
| Shares Out | 136.15M |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 120,663 |
| Open | 0.8000 |
| Previous Close | 0.8320 |
| Day's Range | 0.7720 - 0.8340 |
| 52-Week Range | 0.5600 - 1.3900 |
| Beta | 0.09 |
| Analysts | n/a |
| Price Target | n/a |
| Est. Earnings | Nov 17, 2026 |
About Observe Medical ASA
Observe Medical ASA develops and commercialize medical technology products for patients, healthcare professionals, and hospitals in Europe, Asia, and the Americas. The company offers UnoMeter portfolio comprising Unometer, Safeti Plus, Unometer 500, and UnoMeter AbdoPressure products used for manual urine output measurement and for measuring intra-abdominal pressure. It also provides Sippi, a digital and automated urine measurement system for urine monitoring and biofilm control. Observe Medical ASA was founded in 2009 and is headquartered in O... [Read more]
Financial Performance
In 2025, Observe Medical ASA's revenue was 18.81 million, an increase of 9.18% compared to the previous year's 17.23 million. Losses were -48.64 million, -17.18% less than in 2024.
Financial StatementsNews
Observe Medical ASA Transcript: Trading update
YTD sales grew 51.2% in euros, with growth led by UnoMeter Safeti Plus and order intake accelerating to NOK 5.7m so far in November. Safeti Max is gaining traction, while Sippi moves toward renewed execution and U.S. market preparation.
Observe Medical ASA Slides: Trading update
Observe Medical ASA has posted slides in relation to its latest quarterly earnings report, which was published on November 10, 2026.
Observe Medical ASA Quarterly report: Q2 2026
Observe Medical ASA has published its Q2 2026 quarterly earnings report on August 25, 2026.
Observe Medical ASA Transcript: Trading update
Significant growth achieved with 73% higher order intake and 92% net sales increase, driven by the launch of UnoMeter Safeti Max and expanded global distribution. Clinical validation and sustainability benefits support premium pricing, while digital and operational investments position the company for further market leadership.
Observe Medical ASA Slides: Trading update
Observe Medical ASA has posted slides in relation to its latest quarterly earnings report, which was published on June 26, 2026.
Observe Medical ASA Transcript: Trading update
Sales grew 80% year-on-year, driven by new product launches and expanded distribution, with the business now present in 46 countries and targeting a NOK 2.6 billion market. The company expects to reach cash positivity this year and continues to innovate with products like UnoMeter Safeti Max.
Observe Medical ASA Slides: Trading update
Observe Medical ASA has posted slides in relation to its latest quarterly earnings report, which was published on March 25, 2026.
Observe Medical ASA Quarterly report: Q4 2025
Observe Medical ASA has published its Q4 2025 quarterly earnings report on February 27, 2026.
Observe Medical ASA Annual report: Q4 2025
Observe Medical ASA has published its Q4 2025 annual report on February 27, 2026.